Jessica Lam

Jessica Lam is a seasoned regulatory affairs professional with comprehensive experience in the biotechnology and pharmaceutical industries. Currently serving as Senior Manager of Regulatory Affairs at IO Biotech since June 2022, Jessica has held key roles at companies such as I-Mab Biopharma, NOVAVAX INC, GSK, and Vanda Pharmaceuticals, specializing in regulatory strategy, IND and NDA submissions, and pharmacovigilance activities. Notable competencies include developing regulatory plans, assembling and maintaining submission documents, and collaborating with cross-functional teams. Jessica began their career in clinical operations and gained foundational experience in regulatory processes, documentation, and compliance through various roles, including Clinical Operations Coordinator at TissueGene, Inc. Jessica holds a Bachelor of Science in Biochemistry from Virginia Tech.